MVIS US Listed Pharmaceutical 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that derive at least 50% of their revenues from pharmaceuticals. The pure-play index contains only companies which are engaged primarily engaged in research (incl. research contractors) and development as well as production, marketing and sales of pharmaceuticals. Pharmacies are excluded. The MVIS US Listed Pharmaceutical 25 Index (MVPPH) has been licensed to underlie financial products with currently USD 157.99 million in assets under management.

Components

The MVIS US Listed Pharmaceutical 25 Index counts currently 25 components. The full list of the components with the respective weights is available below.

Items 1-25 of total 25
ComponentCountryWeight
ASTRAZENECA PLC-SPONS ADRGB5.72%
MERCK & CO. INC.US5.22%
ZOETIS INCUS5.19%
NOVARTIS AG-ADRCH5.10%
GLAXOSMITHKLINE PLC-SPON ADRGB5.08%
MYLAN NVNL5.04%
SANOFI-ADRFR5.02%
NOVO-NORDISK A/S-SPONS ADRDK4.97%
MCKESSON CORPUS4.95%
ELI LILLY & COUS4.87%
BAUSCH HEALTH COS INCCA4.69%
JOHNSON & JOHNSONUS4.67%
AMERISOURCEBERGEN CORPUS4.58%
BRISTOL-MYERS SQUIBB COUS4.54%
ABBVIE INCUS4.32%
TAKEDA PHARM-ADRJP4.25%
PFIZER INCUS4.07%
JAZZ PHARMACEUTICALS PLCIE4.06%
TEVA PHARMACEUTICAL-SP ADRIL3.87%
CATALENT INCUS3.17%
GW PHARMACEUTICALS -ADRGB2.82%
PERRIGO CO PLCIE2.59%
PATTERSON COMPANIES INCUS0.70%
ENDO INTERNATIONAL PLCIE0.30%
MALLINCKRODT PLCIE0.19%
Items 1-25 of total 25
Up